Could a simple Under-the-Tongue spray protect kidneys?

NCT ID NCT07187713

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tests a liquid medication called ACE Reno, taken under the tongue four times daily for 12 weeks, in 300 adults with chronic kidney disease from diabetes, high blood pressure, autoimmune disorders, or other causes. The goal is to see if it safely reduces protein in the urine and helps stabilize kidney function. Researchers hope the peptides in ACE Reno can target multiple pathways that drive kidney damage.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
ACE Reno (a solution of bioactive peptides and amino acids taken under the tongue)
What this could lead to
If successful, this could offer a new treatment option to slow kidney disease progression and reduce protein leakage in patients with various causes of chronic kidney disease.
What could go wrong
This is a Phase 4 trial, but results may not apply to all kidney disease types. The treatment effect may be modest, and long-term benefits or risks beyond 12 weeks are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTO IMMUNE DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • British Centre For Regenerative medicine BCRMED Global

    RECRUITING

    Giza, GZ, 12311, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.